UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 324

Sortiert nach

Biomarker-guided therapy for colorectal cancer: strength in complexity

Nature reviews. Clinical oncology, 2020-01, Vol.17 (1), p.11-32

2020

Volltextzugriff (PDF)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models

Scientific reports, 2017-11, Vol.7 (1), p.16618-8, Article 16618

2017

Volltextzugriff (PDF)

Portrait of the PI3K/AKT pathway in colorectal cancer

Biochimica et biophysica acta, 2015-01, Vol.1855 (1), p.104-121

2015

Volltextzugriff (PDF)

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Clinical cancer research, 2018-02, Vol.24 (4), p.794-806

2018

Volltextzugriff (PDF)

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

Molecular cancer, 2017-07, Vol.16 (1), p.116-116, Article 116

2017

Volltextzugriff (PDF)

Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity

European urology, 2019-03, Vol.75 (3), p.498-505

2019

Volltextzugriff (PDF)

Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity

Clinical cancer research, 2020-08, Vol.26 (15), p.4107-4119

2020

Volltextzugriff (PDF)

GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

Neoplasia (New York, N.Y.), 2024-09, Vol.55, p.101023, Article 101023

2024

Volltextzugriff (PDF)

Oncogenicity of the Developmental Transcription Factor Sox9

Cancer research (Chicago, Ill.), 2012-03, Vol.72 (5), p.1301-1315

2012

Volltextzugriff (PDF)

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1651-1659

2015

Volltextzugriff (PDF)

ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients

Clinical cancer research, 2012-11, Vol.18 (21), p.6001-6010

2012

Volltextzugriff (PDF)

Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome

International journal of cancer, 2012-08, Vol.131 (3), p.570-581

2012

Volltextzugriff (PDF)

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer

Nature communications, 2024-05, Vol.15 (1), p.4342-4342, Article 4342

2024

Volltextzugriff (PDF)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer

International journal of cancer, 2019-02, Vol.144 (4), p.841-847

2019

Volltextzugriff (PDF)

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity

Neoplasia (New York, N.Y.), 2021-06, Vol.23 (6), p.634-641

2021

Volltextzugriff (PDF)

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers

International journal of cancer, 2017-09, Vol.141 (5), p.967-976

2017

Volltextzugriff (PDF)

BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures

Stem cell reports, 2013-11, Vol.1 (5), p.379-386

2013

Volltextzugriff (PDF)

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection

PLoS genetics, 2016-07, Vol.12 (7), p.e1006225-e1006225

2016

Volltextzugriff (PDF)

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset

PloS one, 2010-11, Vol.5 (11), p.e13978-e13978

2010

Volltextzugriff (PDF)

MiR-9, -31, and -182 Deregulation Promote Proliferation and Tumor Cell Survival in Colon Cancer

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.868-IN21

2012

Volltextzugriff (PDF)

Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer Survivors

Journal of clinical oncology, 2007-02, Vol.25 (6), p.708-714

2007

Volltextzugriff (PDF)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

Journal of translational medicine, 2012-03, Vol.10 (1), p.36-36, Article 36

2012

Volltextzugriff (PDF)

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases

Journal of translational medicine, 2021-09, Vol.19 (1), p.1-384, Article 384

2021

Volltextzugriff (PDF)

Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1

Genome medicine, 2017-05, Vol.9 (1), p.46-46, Article 46

2017

Volltextzugriff (PDF)

Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma

PloS one, 2012-11, Vol.7 (11), p.e49705-e49705

2012

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(300)
Mit Volltextzugriff
(317)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biomarker-guided therapy for colorectal cancer: strength in complexity

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models

Portrait of the PI3K/AKT pathway in colorectal cancer

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity

Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity

GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

Oncogenicity of the Developmental Transcription Factor Sox9

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients

Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers

BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset

MiR-9, -31, and -182 Deregulation Promote Proliferation and Tumor Cell Survival in Colon Cancer

Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer Survivors

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases

Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1

Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma

Suchergebnisse filtern